Bolt Biotherapeutics Inc (BOLT)

Apr 04, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.38 By Investing.com - Investing.com UK

Apr 04, 2025

Apr 03, 2025

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 03, 2025

Mar 29, 2025

What is HC Wainwright’s Estimate for BOLT Q1 Earnings? - Defense World

Mar 29, 2025

Mar 28, 2025

What is Leerink Partnrs’ Forecast for BOLT Q1 Earnings? - Defense World

Mar 28, 2025

Mar 28, 2025

Q3 Earnings Forecast for BOLT Issued By HC Wainwright - Defense World

Mar 28, 2025

Mar 26, 2025

H.C. Wainwright holds Neutral on Bolt Biotherapeutics stock By Investing.com - Investing.com Australia

Mar 26, 2025

Mar 26, 2025

H.C. Wainwright holds Neutral on Bolt Biotherapeutics stock - Investing.com India

Mar 26, 2025

Mar 26, 2025

Bolt Biotherapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Mar 26, 2025

Mar 26, 2025

Bolt Biotherapeutics Inc (BOLT) Q4 2024 Earnings: EPS Misses at -$0.42, Revenue Falls Short at $0 Million - GuruFocus

Mar 26, 2025

Mar 26, 2025

Bolt Biotherapeutics’ (BOLT) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Mar 26, 2025

Mar 26, 2025

Bolt Biotherapeutics (NASDAQ:BOLT) Given New $1.25 Price Target at Stifel Nicolaus - Defense World

Mar 26, 2025

Mar 25, 2025

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 - The Manila Times

Mar 25, 2025

Mar 25, 2025

Groundbreaking Cancer Drug Trial Results: First-Ever Dectin-2 Agonist Data Revealed at AACR 2025 - Stock Titan

Mar 25, 2025

Mar 25, 2025

Stifel cuts Bolt Biotherapeutics stock price target to $1.25 By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Stifel cuts Bolt Biotherapeutics stock price target to $1.25 - Investing.com

Mar 25, 2025

Mar 24, 2025

Bolt Biotherapeutics Reports 2024 Financial Results and Updates - TipRanks

Mar 24, 2025

Mar 24, 2025

Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - The Washington Post

Mar 24, 2025

Mar 24, 2025

Bolt Biotherapeutics Updates on Clinical Trials and Financial Results, Anticipates Milestones for BDC-4182 and BDC-3042 - Nasdaq

Mar 24, 2025

Mar 24, 2025

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 24, 2025

Mar 22, 2025

BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Mar 22, 2025

Mar 14, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.4 By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.4 - Investing.com India

Mar 14, 2025

Mar 13, 2025

Bolt Biotherapeutics (BOLT) to Release Earnings on Thursday - Defense World

Mar 13, 2025

Mar 08, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.42 By Investing.com - Investing.com Australia

Mar 08, 2025

Mar 07, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.42 - Investing.com India

Mar 07, 2025

Feb 28, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Bolt Biotherapeutics, Inc. (BOLT) - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

BOLT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Bolt Biotherapeutics, Inc. Shareholders Who Lost Money - ACCESS Newswire

Feb 27, 2025

Feb 26, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.46 By Investing.com - Investing.com Canada

Feb 26, 2025

Feb 26, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.46 - Investing.com India

Feb 26, 2025

Feb 25, 2025

Bolt Biotherapeutics to Participate in Upcoming March Conferences - The Manila Times

Feb 25, 2025

Feb 25, 2025

Can Bolt Biotherapeutics' March Conference Appearances Signal New Clinical Developments? - StockTitan

Feb 25, 2025

Feb 24, 2025

Long Term Investors in Bolt Biotherapeutics, Inc. (NASDAQ: - openPR

Feb 24, 2025

Feb 20, 2025

Bolt Biotherapeutics, Inc. (BOLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire

Feb 20, 2025

Feb 18, 2025

Biogen takes territorial rights to Stoke’s Dravet program: Deals Report - BioCentury

Feb 18, 2025

Feb 12, 2025

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc. - The Manila Times

Feb 12, 2025

Feb 11, 2025

Major Cancer Treatment Breakthrough: Bolt and Toray Target Caprin-1 in Solid Tumors - StockTitan

Feb 11, 2025

Feb 10, 2025

BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 10, 2025

Jan 29, 2025

Breast Cancer FDA Approvals, Pipeline Insights, Clinical Trials, Emerging Drugs and Companies | DelveInsight - The Globe and Mail

Jan 29, 2025

Jan 28, 2025

BOLT Stock Earnings: Bolt Biotherapeutics Misses EPS, Beats Revenue for Q2 2024 - MSN

Jan 28, 2025

Jan 04, 2025

Bolt Biotherapeutics shifts to Nasdaq Capital Market By Investing.com - Investing.com Nigeria

Jan 04, 2025

Jan 04, 2025

Bolt Biotherapeutics shifts to Nasdaq Capital Market - Investing.com India

Jan 04, 2025

Dec 31, 2024

Bolt Biotherapeutics, Inc. Announces Board and Committee Changes, Effective December 31, 2024 - Marketscreener.com

Dec 31, 2024

Dec 25, 2024

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Shares Purchased by Fmr LLC - Defense World

Dec 25, 2024